User Name:
Password:
Remember Login:
 
Forgot your password?
 
Or to join, click here.

 












BioHouston thanks our Associate Partners for their support!

Connected Solutions    Ernst & Young    FulBright & Jaworski L.L.P    Mayer Brown           

 
 
 
 
JOIN BIOHOUSTON

BioHouston is supported annually through corporate memberships.  Membership benefits are myriad—to view membership benefits and join, click here.
 
 
BIOHOUSTON RESOURCE CENTER

The BioHouston Resource Center (BRC) makes it easier and more affordable for start-up companies to get to work producing proof-of-concept data, by providing access to wet lab bench space, shared equipment, and the offices and tools that start-up companies need. For more information, click here.

Your support is needed—for more information, click here.
 
 
HIGHLIGHTS

 
OrthoAccel Technologies, Inc. was the winner of the 2007 Michael E. DeBakey Award and $25,000 cash prize. OrthoAccel Technologies, Inc. designs, develops, and markets a revolutionary device that cuts treatment time for braces in half and works in combination with all existing orthodontia bracket technologies. A panel of venture capitalists awarded OrthoAccel Technologies the DeBakey Life Science Award based on its exceptional potential in commercializing its technology. In addition to the $25,000 cash prize, OrthoAccel received a pro bono provisional patent filing from Baker & McKenzie LLP and premier visibility for the year in all BioHouston programs. To provide further support to the emerging companies that win this award, BioHouston offers winners low cost, short-term office space to help further close the funding gaps typically faced by these companies. OrthoAccel became our newest resident company at the beginning of 2008.
 
 
 
CURRENT BIOTECH NEWS

Access Pharmaceuticals Licenses MuGard to Milestone Biosciences

Repros Therapeutics Inc. Provides Update for US Phase II Endometriosis Study & Completion of QT Internal Dose Selection Sceen

Introgen ADVEXIN(R) MAA Accepted for Review by European Medicines Agency

Power3 Medical Products, Inc. Provides Progress Report- NuroPro(R) Clinical Validation Study of Serum Biomarkers for Alzheimer's Disease

Opexa Therapeutics Completes $3 Million Financing

Lexicon Pharmaceuticals Identifies New Drug Candidate for Glaucoma

Repair Stem Cell Institute Announces Industry's First Standards of Excellence for Global Stem Cell Treatment Centers to Protect Patients from Less-Than-Competent Therapeutics

OncoVista Announces Initiation of Research Coverage by Status Equity Research

Introgen Appoints James E. Rothman, Ph.D., to Board of Directors

Caris Diagnostics Launches Target GI for Colon Cancer Patients Coupling Leading Edge Molecular Diagnostics and Anatomic Pathology

Xoft Inc Discovers Electronic Brachytherapy Accurately Delivers Non-Radioactive Therapy Directly to Breast and Endocavitary Cancer Sites


 
 
Save the date! Sponsorship opportunities available...please contact Keisha Curtis at 713.979.9212.
 




Purchase the 2007/2008 Life Science Directory
 
BioHouston